Symbol="GRNA"
AssetType="Common Stock"
Name="Greenlight Biosciences Holdings PBC"
Description="GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for agricultural and human health applications. The company is headquartered in Medford, Massachusetts."
CIK="1822691"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="99 HIGH ST, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="45049300"
EBITDA="-146159008"
PERatio="None"
PEGRatio="None"
BookValue="0.145"
DividendPerShare="0"
DividendYield="0"
EPS="-1.11"
RevenuePerShareTTM="0.073"
ProfitMargin="0"
OperatingMarginTTM="-14.94"
ReturnOnAssetsTTM="-0.818"
ReturnOnEquityTTM="-3.669"
RevenueTTM="10343000"
GrossProfitTTM="-87219000"
DilutedEPSTTM="-1.11"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="13.86"
AnalystTargetPrice="0.45"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="41.41"
PriceToBookRatio="2.136"
EVToRevenue="32.49"
EVToEBITDA="-1.841"
Beta="1.44"
num_52WeekHigh="5.9"
num_52WeekLow="0.177"
num_50DayMovingAverage="0.263"
num_200DayMovingAverage="0.903"
SharesOutstanding="151681000"
DividendDate="None"
ExDividendDate="None"
symbol="GRNA"
open="0.30"
high="0.30"
low="0.30"
price="0.30"
volume="57097.00"
latest_trading_day="2023-07-17"
previous_close="0.30"
change="0.00"
change_percent="0.3704%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="592039"
Change_recent_avg="-0.01"
Delta_recent_avg="0.03"
Variance_recent_avg="0.02"
Change_ratio_recent_avg="-2.43"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1091"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_negative_thumbnail_id_2="119"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0057.jpeg"
image_neutral_thumbnail_id_1="527"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="685"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0023.jpeg"
image_positive_thumbnail_id_2="610"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0098.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
